Thoracic Aorta




Key Points




  • 1.

    Diseases of the thoracic aorta can occasionally be managed with medical treatment and surveillance, whereas others require surgical intervention. Depending on the disease process, some surgeries may be performed electively, whereas others are truly emergency operations.


  • 2.

    Aortic surgery is complex, and therefore it requires an anesthetic tailored to the specific goals for hemodynamics, neuromonitoring, and cerebral/spinal cord perfusion.


  • 3.

    Thoracic aortic aneurysms can cause compression of the trachea, left mainstem bronchus, right ventricular outflow tract, right pulmonary artery, or esophagus.


  • 4.

    Deliberate hypothermia is the most important therapeutic intervention to prevent cerebral ischemia during temporary interruption of cerebral perfusion during aortic arch reconstruction.


  • 5.

    Early detection and interventions to increase spinal cord perfusion pressure are effective for the treatment of delayed-onset spinal cord ischemia after thoracic or thoracoabdominal aortic aneurysm repair.


  • 6.

    Severe atheromatous disease or thrombus in the thoracic or descending aorta is a risk factor for stroke.


  • 7.

    Stanford type A dissection, involving the ascending aorta and aortic arch, is a surgical emergency. Stanford type B dissection, confined to the descending thoracic or abdominal aorta, should be managed medically when possible.


  • 8.

    When adequate preoperative imaging is lacking, intraoperative transesophageal echocardiography can be used to diagnose type A dissection or traumatic aortic injuries that require emergency surgery.


  • 9.

    Intraoperative transesophageal echocardiography and ultrasound imaging of the carotid arteries are useful for the diagnosis of aortic regurgitation, cardiac tamponade, myocardial ischemia, or cerebral malperfusion, complicating type A aortic dissection.


  • 10.

    Newer endovascular approaches to the management of thoracic aortic disease continue to have a great impact on both elective and emergent aortic surgery.



Thoracic aortic diseases typically require surgical intervention ( Box 17.1 ). Acute aortic dissections, rupturing aortic aneurysms, and traumatic aortic injuries are surgical emergencies. Subacute aortic dissection and expanding aortic aneurysms require urgent surgical intervention. Stable thoracic or thoracoabdominal aortic aneurysms (TAAAs), aortic coarctation, or atheromatous disease causing embolization may be addressed surgically on an elective basis. The volume of thoracic aortic procedures has grown steadily because of factors such as increased public awareness, an aging population, earlier diagnosis, multiple advances in imaging, and advances in surgical techniques, including endovascular stenting. Medical centers have emerged that specialize in thoracic aortic diseases, resulting in improved management and survival. This progress has created a set of patients who later require reoperation for long-term complications such as valve or graft failure, pseudoaneurysm at anastomotic sites, endocarditis, and/or progression of the original disease process into the residual native aorta.



Box 17.1

Thoracic Aortic Diseases Amenable to Surgical Treatment





  • Aneurysm



  • Congenital or developmental




    • Marfan syndrome, Ehlers-Danlos syndrome




  • Degenerative




    • Cystic medial degeneration



    • Annuloaortic ectasia



    • Atherosclerotic




  • Traumatic




    • Blunt and penetrating trauma




  • Inflammatory




    • Takayasu arteritis, Behçet syndrome, Kawasaki disease




  • Microvascular diseases (polyarteritis)



  • Infectious (mycotic)




    • Bacterial, fungal, spirochetal, viral




  • Mechanical




    • Poststenotic, associated with an arteriovenous fistula



    • Anastomotic (postarteriotomy)




  • Pseudoaneurysm



  • Aortic dissection




    • Stanford type A



    • Stanford type B




  • Intramural hematoma



  • Penetrating atherosclerotic ulcer



  • Traumatic aortic injury



  • Aortic coarctation



Data from Kouchoukos NT, Dougenis D. Surgery of the aorta. N Engl J Med . 1997;336:1876–1878.


The anesthetic management of thoracic aortic diseases has unique considerations, including the temporary interruption of blood flow, often resulting in ischemia of major organ systems. Critical components of anesthetic management include the maintenance of organ perfusion, protection of vital organs during ischemia, and monitoring and management of end-organ ischemia. As a result, the vigilant and skillful anesthesiologist contributes significantly to the overall success of these operations. The procedures performed by the thoracic aortic team for organ protection, such as partial left-heart bypass (PLHB) for distal aortic perfusion, cardiopulmonary bypass (CPB) with deep hypothermic circulatory arrest (DHCA), selective cerebral perfusion, and lumbar cerebrospinal fluid (CSF) drainage, are practiced routinely in no other area of medicine.




General Considerations for the Perioperative Care of Aortic Surgical Patients


Patients undergoing thoracic aortic surgery require the common considerations for the safe use of anesthesia and perioperative care that are addressed in this section ( Box 17.2 ).



Box 17.2

Anesthetic Considerations for the Care of Thoracic Aortic Surgical Patients


Preanesthetic Assessment





  • Urgency of the operation (emergent, urgent, or elective)



  • Pathology and anatomic extent of the disease



  • Median sternotomy vs thoracotomy vs endovascular approach



  • Mediastinal mass effect



  • Airway compression or deviation



Preexisting or Associated Medical Conditions





  • Aortic valve disease



  • Cardiac tamponade



  • Coronary artery stenosis



  • Cardiomyopathy



  • Cerebrovascular disease



  • Pulmonary disease



  • Renal insufficiency



  • Esophageal disease (contraindications to transesophageal echocardiography [TEE])



  • Coagulopathy



  • Prior aortic operations



Preoperative Medications





  • Warfarin (Coumadin)



  • Antiplatelet therapy



  • Antihypertensive therapy



Anesthetic Management





  • Hemodynamic monitoring




    • Proximal aortic pressure



    • Distal aortic pressure



    • Central venous pressure



    • Pulmonary artery pressure and cardiac output



    • TEE




  • Neurophysiologic monitoring




    • Electroencephalography



    • Somatosensory-evoked potentials



    • Motor-evoked potentials



    • Jugular venous oxygen saturation



    • Lumbar cerebrospinal fluid pressure



    • Body temperature




  • Single-lung ventilation for thoracotomy




    • Double-lumen endobronchial tube



    • Endobronchial blocker




  • Potential for bleeding




    • Large-bore intravenous access



    • Blood product availability



    • Antifibrinolytic therapy




  • Antibiotic prophylaxis



Postoperative Care Considerations and Complications





  • Hypothermia



  • Hypotension



  • Hypertension



  • Bleeding



  • Spinal cord ischemia



  • Stroke



  • Renal insufficiency



  • Respiratory insufficiency



  • Phrenic nerve injury



  • Diaphragmatic dysfunction



  • Recurrent laryngeal nerve injury



  • Pain management




Preanesthetic Assessment


Identification of the aortic diagnosis is paramount because its extent and physiologic consequences dictate both anesthetic management and surgical approach. Aortic diseases proximal to the left carotid artery typically are approached via a median sternotomy, whereas aortic diseases distal to this point usually are approached via a left thoracotomy or thoracoabdominal incision. Although an aortic diagnosis often is established in advance, at times a definitive diagnosis must be verified after operating room (OR) admission by direct review of diagnostic studies or by subsequent transesophageal echocardiography (TEE). In every case, a review of the operative plan with the surgical team facilitates thorough anesthetic preparation. Direct review of adequate aortic diagnostic imaging studies not only verifies the operative diagnosis but also determines the surgical possibilities. The anatomic details of an aortic disease permit the anesthesiologist to anticipate potential perioperative difficulties, including likely postoperative complications.


Anesthetic Management


Inherent in surgical procedure is the potential for massive bleeding and cardiovascular collapse. Therefore, it is essential to have immediate availability of packed red blood cells and clotting factors, large-bore vascular access, invasive blood pressure monitoring, and central venous access. Pulmonary artery catheterization assists in the management of cardiac dysfunction associated with CPB, DHCA, and PLHB. Intraoperative TEE is indicated in thoracic aortic procedures, including endovascular interventions, in which it assists in hemodynamic monitoring, procedural guidance, and endoleak detection A rationale exists for choosing to cannulate the left or right radial artery for intraarterial blood pressure monitoring. Right radial arterial pressure monitoring will often detect compromised flow into the brachiocephalic artery because of aortic cross-clamping too near its origin. Right radial arterial pressure monitoring also makes sense in procedures that require clamping of the left subclavian artery. Left radial arterial pressure monitoring is indicated when selective antegrade cerebral perfusion (ACP) is planned via the right axillary artery; however, a right-sided catheter may be preferred for ACP if direct brachiocephalic cannulation is used by the surgeon. At times, bilateral radial arterial pressure monitoring may be required. Femoral arterial pressure monitoring allows the assessment of distal aortic perfusion in procedures with PLHB.


Large-bore peripheral intravenous cannulation secures vascular access for rapid intravascular volume expansion. Rapid transfusion is desirable via an intravenous set with a fluid-warming device. Alternatively, large-bore central venous cannulation can be utilized for volume expansion. If a pulmonary artery catheter (PAC) is required, a second introducer sheath dedicated to volume expansion also can be placed in the same central vein. Central venous cannulation with ultrasound guidance often increases speed and safety, especially in emergencies. Both a urinary and a nasopharyngeal temperature probe are required for monitoring the absolute temperature of the periphery and core, as well as the rates of change during deliberate hypothermia and subsequent rewarming. The rectum is an alternative site for monitoring peripheral temperature, and the PAC can provide core temperature monitoring.


The induction of general anesthesia requires careful hemodynamic monitoring with anticipation of changes because of anesthetic drugs and tracheal intubation. Appropriate vasoactive drugs should be immediately available as required. Concomitant vasodilator infusions often are discontinued before anesthetic induction. Because etomidate does not attenuate sympathetic responses and has no direct effects on myocardial contractility, it may be preferred in the setting of hemodynamic instability. Thereafter, titration of a narcotic such as fentanyl and a benzodiazepine such as midazolam will provide maintenance of general anesthesia. In elective cases, anesthetic induction can proceed with routine intravenous hypnotics, followed by narcotic titration for attenuation of the hypertensive responses to tracheal intubation and skin incision. Antibiotic therapy optimally should be completed in most cases at least 30 minutes before skin incision to achieve adequate bactericidal tissue levels.


General anesthetic maintenance is typically with a balanced intravenous and inhalation anesthetic technique, and neuromuscular blockade is achieved by titration of a nondepolarizing muscle relaxant. Anesthetics can be reduced during moderate hypothermia and then discontinued during deep hypothermia. With concomitant electroencephalographic (EEG) and/or somatosensory-evoked potential (SSEP) monitoring, anesthetic signal interference is minimized with the avoidance of barbiturates, bolus propofol, and doses of inhaled anesthetic greater than 0.5 minimum alveolar concentration. Propofol infusion, narcotics, and neuromuscular blocking drugs do not interfere with SSEP monitoring. With intraoperative motor-evoked potential (MEP) monitoring, high-quality signals are obtained when the anesthetic technique comprises total intravenous anesthesia with propofol and a narcotic such as remifentanil without neuromuscular blockade.


The potential for significant bleeding and rapid transfusion is always relevant in thoracic aortic procedures. Consequently, it is prudent to have fresh frozen plasma and platelets available for ongoing replacement during massive red blood cell transfusion. The time delay associated with standard laboratory testing severely limits the intraoperative relevance of these data to guide transfusion; however, viscoelastic tests are being used with greater frequency to determine coagulation needs. Strategies to decrease bleeding and transfusion in these procedures include timely preoperative cessation of anticoagulants and platelet blockers, antifibrinolytic therapy, intraoperative cell salvage, biologic glue, activated factor VII, and avoidance of perioperative hypertension. The antifibrinolytic lysine analogs, epsilon-aminocaproic acid or tranexamic acid, are the commonly utilized blood conservation agents in thoracic aortic surgery with and without DHCA. Recombinant activated factor VII is a synthetic agent that accelerates thrombin production leading to hemostasis, and it may be considered for the management of intractable nonsurgical bleeding after CPB that is unresponsive to routine therapy. Although this agent has demonstrated efficacy in complex aortic surgery, concerns for arterial thrombotic events remain, requiring further trials to investigate perioperative safety. Finally, the use of fibrinogen concentrates in the management of coagulopathy continue to be investigated in cardiac surgery, with recent evidence suggesting decreased intraoperative bleeding when fibrinogen concentrates are used as a first-line therapy for coagulopathy after major aortic surgery.


Postoperative Care


With the exception of some endovascular aortic procedures, patients often remain intubated and sedated at the completion of the operation, when they are transported directly from the OR to the intensive care unit (ICU). The continuation of care from the OR to the ICU should be seamless and protocol-based. In the absence of complications, early anesthetic emergence is preferable for early assessment of neurologic function. If delayed anesthetic emergence is indicated, then sedation and analgesia can be provided. The chest roentgenogram allows confirmation of endotracheal tube and intravascular catheter position, as well as the diagnosis of acute intrathoracic pathologies. Common early complications include hypothermia, coagulopathy, delirium, stroke, hemodynamic lability, respiratory failure, metabolic disturbances, and renal failure. Frequent clinical and laboratory assessment is essential to manage this dynamic postoperative recovery, including the safe conduct of tracheal extubation. Given the risks associated with hyperglycemia after cardiac surgery, management of blood glucose levels should be standardized, with more recent data to suggest more liberal control (glucose less than 180 mg/dL) is acceptable with good outcomes. Antibiotic prophylaxis is typically continued for 48 hours after surgery to minimize surgical infection risk.




General Considerations for the Perioperative Care of Aortic Surgical Patients


Patients undergoing thoracic aortic surgery require the common considerations for the safe use of anesthesia and perioperative care that are addressed in this section ( Box 17.2 ).



Box 17.2

Anesthetic Considerations for the Care of Thoracic Aortic Surgical Patients


Preanesthetic Assessment





  • Urgency of the operation (emergent, urgent, or elective)



  • Pathology and anatomic extent of the disease



  • Median sternotomy vs thoracotomy vs endovascular approach



  • Mediastinal mass effect



  • Airway compression or deviation



Preexisting or Associated Medical Conditions





  • Aortic valve disease



  • Cardiac tamponade



  • Coronary artery stenosis



  • Cardiomyopathy



  • Cerebrovascular disease



  • Pulmonary disease



  • Renal insufficiency



  • Esophageal disease (contraindications to transesophageal echocardiography [TEE])



  • Coagulopathy



  • Prior aortic operations



Preoperative Medications





  • Warfarin (Coumadin)



  • Antiplatelet therapy



  • Antihypertensive therapy



Anesthetic Management





  • Hemodynamic monitoring




    • Proximal aortic pressure



    • Distal aortic pressure



    • Central venous pressure



    • Pulmonary artery pressure and cardiac output



    • TEE




  • Neurophysiologic monitoring




    • Electroencephalography



    • Somatosensory-evoked potentials



    • Motor-evoked potentials



    • Jugular venous oxygen saturation



    • Lumbar cerebrospinal fluid pressure



    • Body temperature




  • Single-lung ventilation for thoracotomy




    • Double-lumen endobronchial tube



    • Endobronchial blocker




  • Potential for bleeding




    • Large-bore intravenous access



    • Blood product availability



    • Antifibrinolytic therapy




  • Antibiotic prophylaxis



Postoperative Care Considerations and Complications





  • Hypothermia



  • Hypotension



  • Hypertension



  • Bleeding



  • Spinal cord ischemia



  • Stroke



  • Renal insufficiency



  • Respiratory insufficiency



  • Phrenic nerve injury



  • Diaphragmatic dysfunction



  • Recurrent laryngeal nerve injury



  • Pain management




Preanesthetic Assessment


Identification of the aortic diagnosis is paramount because its extent and physiologic consequences dictate both anesthetic management and surgical approach. Aortic diseases proximal to the left carotid artery typically are approached via a median sternotomy, whereas aortic diseases distal to this point usually are approached via a left thoracotomy or thoracoabdominal incision. Although an aortic diagnosis often is established in advance, at times a definitive diagnosis must be verified after operating room (OR) admission by direct review of diagnostic studies or by subsequent transesophageal echocardiography (TEE). In every case, a review of the operative plan with the surgical team facilitates thorough anesthetic preparation. Direct review of adequate aortic diagnostic imaging studies not only verifies the operative diagnosis but also determines the surgical possibilities. The anatomic details of an aortic disease permit the anesthesiologist to anticipate potential perioperative difficulties, including likely postoperative complications.


Anesthetic Management


Inherent in surgical procedure is the potential for massive bleeding and cardiovascular collapse. Therefore, it is essential to have immediate availability of packed red blood cells and clotting factors, large-bore vascular access, invasive blood pressure monitoring, and central venous access. Pulmonary artery catheterization assists in the management of cardiac dysfunction associated with CPB, DHCA, and PLHB. Intraoperative TEE is indicated in thoracic aortic procedures, including endovascular interventions, in which it assists in hemodynamic monitoring, procedural guidance, and endoleak detection A rationale exists for choosing to cannulate the left or right radial artery for intraarterial blood pressure monitoring. Right radial arterial pressure monitoring will often detect compromised flow into the brachiocephalic artery because of aortic cross-clamping too near its origin. Right radial arterial pressure monitoring also makes sense in procedures that require clamping of the left subclavian artery. Left radial arterial pressure monitoring is indicated when selective antegrade cerebral perfusion (ACP) is planned via the right axillary artery; however, a right-sided catheter may be preferred for ACP if direct brachiocephalic cannulation is used by the surgeon. At times, bilateral radial arterial pressure monitoring may be required. Femoral arterial pressure monitoring allows the assessment of distal aortic perfusion in procedures with PLHB.


Large-bore peripheral intravenous cannulation secures vascular access for rapid intravascular volume expansion. Rapid transfusion is desirable via an intravenous set with a fluid-warming device. Alternatively, large-bore central venous cannulation can be utilized for volume expansion. If a pulmonary artery catheter (PAC) is required, a second introducer sheath dedicated to volume expansion also can be placed in the same central vein. Central venous cannulation with ultrasound guidance often increases speed and safety, especially in emergencies. Both a urinary and a nasopharyngeal temperature probe are required for monitoring the absolute temperature of the periphery and core, as well as the rates of change during deliberate hypothermia and subsequent rewarming. The rectum is an alternative site for monitoring peripheral temperature, and the PAC can provide core temperature monitoring.


The induction of general anesthesia requires careful hemodynamic monitoring with anticipation of changes because of anesthetic drugs and tracheal intubation. Appropriate vasoactive drugs should be immediately available as required. Concomitant vasodilator infusions often are discontinued before anesthetic induction. Because etomidate does not attenuate sympathetic responses and has no direct effects on myocardial contractility, it may be preferred in the setting of hemodynamic instability. Thereafter, titration of a narcotic such as fentanyl and a benzodiazepine such as midazolam will provide maintenance of general anesthesia. In elective cases, anesthetic induction can proceed with routine intravenous hypnotics, followed by narcotic titration for attenuation of the hypertensive responses to tracheal intubation and skin incision. Antibiotic therapy optimally should be completed in most cases at least 30 minutes before skin incision to achieve adequate bactericidal tissue levels.


General anesthetic maintenance is typically with a balanced intravenous and inhalation anesthetic technique, and neuromuscular blockade is achieved by titration of a nondepolarizing muscle relaxant. Anesthetics can be reduced during moderate hypothermia and then discontinued during deep hypothermia. With concomitant electroencephalographic (EEG) and/or somatosensory-evoked potential (SSEP) monitoring, anesthetic signal interference is minimized with the avoidance of barbiturates, bolus propofol, and doses of inhaled anesthetic greater than 0.5 minimum alveolar concentration. Propofol infusion, narcotics, and neuromuscular blocking drugs do not interfere with SSEP monitoring. With intraoperative motor-evoked potential (MEP) monitoring, high-quality signals are obtained when the anesthetic technique comprises total intravenous anesthesia with propofol and a narcotic such as remifentanil without neuromuscular blockade.


The potential for significant bleeding and rapid transfusion is always relevant in thoracic aortic procedures. Consequently, it is prudent to have fresh frozen plasma and platelets available for ongoing replacement during massive red blood cell transfusion. The time delay associated with standard laboratory testing severely limits the intraoperative relevance of these data to guide transfusion; however, viscoelastic tests are being used with greater frequency to determine coagulation needs. Strategies to decrease bleeding and transfusion in these procedures include timely preoperative cessation of anticoagulants and platelet blockers, antifibrinolytic therapy, intraoperative cell salvage, biologic glue, activated factor VII, and avoidance of perioperative hypertension. The antifibrinolytic lysine analogs, epsilon-aminocaproic acid or tranexamic acid, are the commonly utilized blood conservation agents in thoracic aortic surgery with and without DHCA. Recombinant activated factor VII is a synthetic agent that accelerates thrombin production leading to hemostasis, and it may be considered for the management of intractable nonsurgical bleeding after CPB that is unresponsive to routine therapy. Although this agent has demonstrated efficacy in complex aortic surgery, concerns for arterial thrombotic events remain, requiring further trials to investigate perioperative safety. Finally, the use of fibrinogen concentrates in the management of coagulopathy continue to be investigated in cardiac surgery, with recent evidence suggesting decreased intraoperative bleeding when fibrinogen concentrates are used as a first-line therapy for coagulopathy after major aortic surgery.


Postoperative Care


With the exception of some endovascular aortic procedures, patients often remain intubated and sedated at the completion of the operation, when they are transported directly from the OR to the intensive care unit (ICU). The continuation of care from the OR to the ICU should be seamless and protocol-based. In the absence of complications, early anesthetic emergence is preferable for early assessment of neurologic function. If delayed anesthetic emergence is indicated, then sedation and analgesia can be provided. The chest roentgenogram allows confirmation of endotracheal tube and intravascular catheter position, as well as the diagnosis of acute intrathoracic pathologies. Common early complications include hypothermia, coagulopathy, delirium, stroke, hemodynamic lability, respiratory failure, metabolic disturbances, and renal failure. Frequent clinical and laboratory assessment is essential to manage this dynamic postoperative recovery, including the safe conduct of tracheal extubation. Given the risks associated with hyperglycemia after cardiac surgery, management of blood glucose levels should be standardized, with more recent data to suggest more liberal control (glucose less than 180 mg/dL) is acceptable with good outcomes. Antibiotic prophylaxis is typically continued for 48 hours after surgery to minimize surgical infection risk.

Only gold members can continue reading. Log In or Register to continue

Sep 1, 2018 | Posted by in ANESTHESIA | Comments Off on Thoracic Aorta

Full access? Get Clinical Tree

Get Clinical Tree app for offline access